$5.98 -0.14 (-2.29%)
11/25/2009 4:00 PM

Halozyme Therapeutics, Inc. (HALO)

CAPS Rating: 2 out of 5

A biopharmaceutical company dedicated to the development and commercialization of recombinant human enzymes for the drug delivery, palliative care, oncology and infertility markets.

Featured Broker Partners